Hestia Insight Inc. (HSTA) Stock Analysis

Hestia Insight Inc. (HSTA) Technology Profile & Competitive Position

Hestia Insight Inc. is a Las Vegas-based technology firm delivering specialized strategic consulting and capital market advisory services to small and mid-sized businesses across the healthcare, biotech, and fintech sectors. The company also engages in healthcare technology analysis, medical supply sales management, and comprehensive sales and marketing strategy, positioning itself as a diversified solutions provider in niche markets.

What Is the Investment Thesis for HSTA?

Hestia Insight Inc. operates in a specialized niche, offering strategic consulting and technology solutions to the healthcare, biotech, and fintech sectors, which are characterized by ongoing innovation and demand for expert guidance. The company's diversified service portfolio, encompassing capital market advisory, healthcare technology analysis, and medical supply sales management, positions it to capture revenue streams from multiple angles within these high-growth industries. With a market capitalization of $1.06 million, the company represents a micro-cap entity with potential for significant percentage growth from a low base, assuming successful execution of its service offerings and client acquisition. The increasing demand for data analytics and specialized technology solutions across industries, as highlighted by AI insights, provides a favorable market backdrop for Hestia Insight Inc.'s technology-focused services. However, its trading on the OTC Other tier and unknown disclosure status introduce higher inherent risks, including potential volatility and limited public information, necessitating thorough due diligence by investors.

Based on FMP financials and quantitative analysis

HSTA Key Highlights

Hestia Insight Inc. operates with a market capitalization of $0.00B, reflecting its status as a micro-cap entity within the technology sector.

• The company exhibits a Beta of 0.25, suggesting lower volatility relative to the broader market, though this can be influenced by its OTC listing.
• Hestia Insight Inc. does not currently pay a dividend, consistent with many growth-oriented or smaller technology firms.
• The company's share price of $0.03 and market capitalization of $1.06 million (as per AI insight) indicate its micro-cap valuation and potential for significant price sensitivity.
• Hestia Insight Inc. maintains a lean operational structure with 3 employees, focusing on specialized consulting and technology services.

Who Are HSTA's Competitors?

HSTA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HSTA's Key Strengths?

Specialized expertise in high-growth sectors: healthcare, biotech, and fintech.

• Diversified service portfolio including consulting, tech analysis, and sales management.
• Focused approach on small to mid-sized businesses, potentially leading to deeper client relationships.
• Involvement in developing and analyzing healthcare technologies for neurological and psychiatric conditions, addressing critical market needs.
• Lean operational structure with 3 employees, potentially allowing for agility and cost efficiency.

What Are HSTA's Weaknesses?

Very small employee base (3 employees) may limit capacity for large projects or rapid expansion.

• Market capitalization of $0.00B (or $1.06 million) indicates limited financial resources and market presence.
• Trading on the OTC Other tier, which often implies lower transparency and higher risk for investors.
• Unknown disclosure status, making it difficult for investors to access comprehensive financial and operational information.
• Potential for high volatility due to its micro-cap status and OTC listing.

What Could Drive HSTA Stock Higher?

HSTA catalyst: Potential for new client acquisitions within the high-growth healthcare, biotech, or fintech sectors, driving service revenue.

• Continued demand for specialized strategic consulting and capital market advisory services in niche markets.
• Development or successful implementation of new healthcare technologies, particularly for neurological and psychiatric conditions, expanding service offerings.
• Expansion of medical supply sales management contracts, contributing to consistent service income.
• Any improvements in disclosure status on the OTC Markets, potentially increasing investor confidence and liquidity.

What Are the Key Risks for HSTA?

Financial-distress signal — its Altman Z-Score of -11.06 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• High operational risk due to a very small employee base (3 employees), potentially limiting scalability and resilience.
• Significant market volatility and liquidity challenges inherent with trading on the OTC Other tier and a micro-cap valuation.
• disclosure status poses a substantial risk, as investors lack access to critical financial and operational information.
• Intense competition from larger, more established consulting firms and technology providers in its target sectors.
• Dependence on a limited number of clients or projects for revenue generation, given its small scale and specialized focus.

What Are the Growth Opportunities for HSTA?

• Growth in specialized healthcare technology consulting represents a significant opportunity for Hestia Insight Inc. The global healthcare IT market is projected to reach substantial valuations, driven by digital transformation, telemedicine adoption, and data analytics in patient care. Hestia Insight Inc.'s expertise in creating and analyzing healthcare technologies, especially for neurological and psychiatric conditions, positions it to capitalize on the increasing demand for innovative solutions in these complex medical fields. By expanding its client base among small to mid-sized healthcare businesses seeking to integrate advanced technologies, the company can leverage its niche specialization to secure new contracts and enhance its market presence over the next 3-5 years.
• Expansion within the biotech advisory segment offers another robust growth avenue. The biotechnology sector is characterized by high R&D investment, complex regulatory pathways, and significant capital needs, making strategic and capital market advisory services invaluable. Hestia Insight Inc.'s ability to provide tailored support to small to mid-sized biotech firms can help these companies navigate funding rounds, market entry, and strategic partnerships. As biotech innovation continues to accelerate globally, with new therapies and diagnostics emerging, the demand for expert guidance on market positioning and capital acquisition will likely grow, providing a sustained opportunity for Hestia Insight Inc. over the medium term.
• The burgeoning fintech sector presents a notable opportunity for Hestia Insight Inc.'s strategic consulting and capital market advisory services. The financial technology market is experiencing rapid disruption and growth, with new startups and established institutions seeking to leverage technology for improved efficiency, customer experience, and compliance. Small to mid-sized fintech companies often require specialized expertise to scale, secure funding, and navigate evolving regulatory landscapes. Hestia Insight Inc. can expand its footprint by offering bespoke solutions that address these critical needs, helping clients develop robust business models and attract investment. This market segment is expected to continue its strong growth trajectory for the foreseeable future.
• Increasing demand for specialized medical supply sales management and assistance provides a practical growth opportunity. The medical supply chain is intricate, requiring efficient management, regulatory compliance, and effective sales strategies. Small to mid-sized businesses in the healthcare sector often lack the internal resources or expertise to optimize their medical supply operations. Hestia Insight Inc.'s service offering in this area can provide a crucial outsourced solution, helping clients streamline sales processes, manage inventory, and enhance market penetration. As healthcare providers continue to seek cost efficiencies and operational improvements, the need for expert assistance in medical supply sales is likely to remain strong, offering a stable revenue stream.
• The provision of comprehensive sales and marketing strategy and guidance to its target client base represents a cross-cutting growth driver. Regardless of their specific industry (healthcare, biotech, or fintech), small to mid-sized businesses consistently require effective strategies to acquire customers, build brand awareness, and drive revenue growth. Hestia Insight Inc.'s ability to offer tailored sales and marketing solutions, leveraging its industry-specific insights, can be a significant value proposition. By helping clients optimize their go-to-market strategies and improve sales performance, Hestia Insight Inc. can deepen client relationships and attract new businesses seeking to enhance their commercial effectiveness, fostering long-term engagement and revenue growth.

What Threats Does HSTA Face?

• Intense competition from larger, more established consulting firms and specialized technology providers.
• Regulatory changes in the healthcare, biotech, or fintech sectors could impact client demand or operational requirements.
• Economic downturns could reduce demand for consulting and advisory services from small to mid-sized businesses.
• High risk profile associated with OTC Other listing, potentially deterring institutional investors.
• Challenges in attracting and retaining highly skilled talent given the small employee base and competitive industry.

What Are HSTA's Competitive Advantages?

• Specialized multi-sector expertise across healthcare, biotech, and fintech, offering integrated solutions.
• Niche focus on healthcare technologies for neurological and psychiatric conditions, differentiating its tech analysis services.
• Comprehensive service offering from capital market advisory to medical supply sales management, creating a 'one-stop-shop' for specific client needs.
• Agile operational structure with a small team, potentially allowing for highly customized and responsive client engagement.
• Established presence and rebranding in 2019, indicating a strategic evolution and commitment to its defined market segments.

What Does HSTA Do?

Hestia Insight Inc., headquartered in Las Vegas, Nevada, operates within the technology sector, providing a specialized suite of services primarily to small to mid-sized businesses. The company's core offerings revolve around strategic consulting and capital market advisory support, with a distinct focus on the healthcare, biotech, and fintech industries. This targeted approach allows Hestia Insight Inc. to address the unique challenges and opportunities within these complex and rapidly evolving sectors. Beyond advisory services, the firm extends its portfolio to include healthcare management and patient-focused solutions, indicating a commitment to operational efficiency and improved patient outcomes within the medical field. A significant component of Hestia Insight Inc.'s business involves the creation and analysis of healthcare technologies, particularly those designed to address neurological and psychiatric conditions. This engagement in technology development and assessment underscores its position within the software and application space, aiming to innovate within critical healthcare areas. Furthermore, the company offers comprehensive management and assistance for medical supply sales, providing crucial support for businesses navigating the procurement and distribution of medical products. Complementing these services, Hestia Insight Inc. delivers extensive sales and marketing strategy and guidance, helping its clients effectively reach their target markets and achieve growth objectives. The company, formerly known as Luxshmi Investments, Inc., underwent a rebranding to Hestia Insight Inc. in May 2019, marking a strategic evolution in its corporate identity and service focus. With a lean operational structure, employing 3 individuals, Hestia Insight Inc. aims to deliver high-value, specialized expertise to its niche client base.

What Products and Services Does HSTA Offer?

• Provides specialized strategic consulting services to businesses.
• Offers capital market advisory support, particularly for small to mid-sized enterprises.
• Focuses services on the healthcare, biotech, and fintech sectors.
• Delivers healthcare management and patient-focused solutions.
• Engages in the creation and analysis of healthcare technologies, especially for neurological and psychiatric conditions.
• Manages and assists with medical supply sales for clients.
• Provides comprehensive sales and marketing strategy and guidance.

How Does HSTA Make Money?

• Generates revenue through fees for strategic consulting and capital market advisory services.
• Earns income from providing healthcare management and patient-focused solutions.
• Monetizes its expertise in healthcare technology creation and analysis through project-based work or service contracts.
• Receives fees for managing and assisting with medical supply sales, potentially on a commission or retainer basis.
• Charges for developing and implementing sales and marketing strategies for clients.

What Industry Does HSTA Operate In?

Hestia Insight Inc. is positioned within the Software - Application industry, specifically targeting the healthcare, biotech, and fintech sectors with its consulting and technology analysis services. These industries are characterized by rapid technological advancements, stringent regulatory environments, and a continuous need for specialized software solutions and strategic guidance. The broader technology sector continues to experience robust growth, driven by digital transformation initiatives, cloud adoption, and the increasing demand for data analytics. Hestia Insight Inc.'s focus on healthcare technologies, particularly for neurological and psychiatric conditions, places it in a niche within the burgeoning health tech market, which is experiencing significant investment and innovation. Similarly, its involvement in fintech advisory aligns with the ongoing disruption and digital evolution within financial services. The competitive landscape includes a mix of larger consulting firms, specialized boutique advisories, and technology providers. Hestia Insight Inc. differentiates itself through its multi-sector focus and comprehensive service offering, from capital market advisory to medical supply sales management.

Who Are HSTA's Key Customers?

• Small to mid-sized businesses within the healthcare industry.
• Emerging and established companies in the biotechnology sector.
• Fintech startups and growing enterprises seeking strategic guidance.
• Organizations requiring specialized healthcare technology development or analysis.
• Medical supply companies or healthcare providers needing sales and marketing support.

The most recent 4 insider filings for Hestia Insight Inc. break down as 3 sales and 1 purchases. On net that is roughly 1.2M shares disposed (about $555), a signal worth weighing alongside the fundamentals.

Hestia Insight Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -11.06 places it in the distress zone, a signal of elevated financial risk.

Key Financial Metrics

Its free cash flow yield is -18.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.57 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -92.8%, the inverse of the P/E and a quick read on earnings relative to price.

HSTA Revenue & Earnings Trend

In Q2 FY2026, HSTA generated $16K in top-line revenue. The company recorded a net loss of $482K, with diluted EPS of $-0.02. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this unknown Technology company. Across the four most recent quarters, HSTA averaged $-0.01 in diluted EPS.

Company Profile

Hestia Insight Inc. operates in the Software - Application industry within the Technology sector. It is headquartered in Las Vegas, US. The company is led by CEO Edward C. Lee. HSTA has traded publicly since 2009.

HSTA Financials

HSTA Latest News

HSTA Analyst Consensus

HSTA MoonshotScore

Common Questions About HSTA (Technology)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources